New therapy for the treatment of urothelial cancer

New therapy for the treatment of urothelial cancer

An international clinical trial of a treatment for advanced urothelial cancer has found a new dual therapy can nearly double patients’ life expectancy. The new immunotherapy is a combination of two drugs – enfortumab vedotin (EV) and pembrolizumab – delivered by...